0000812295-15-000041.txt : 20150218
0000812295-15-000041.hdr.sgml : 20150216
20150217191039
ACCESSION NUMBER: 0000812295-15-000041
CONFORMED SUBMISSION TYPE: SC 13G
PUBLIC DOCUMENT COUNT: 1
FILED AS OF DATE: 20150218
DATE AS OF CHANGE: 20150217
SUBJECT COMPANY:
COMPANY DATA:
COMPANY CONFORMED NAME: PERNIX THERAPEUTICS HOLDINGS, INC.
CENTRAL INDEX KEY: 0001024126
STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834]
IRS NUMBER: 330724736
STATE OF INCORPORATION: MD
FISCAL YEAR END: 1231
FILING VALUES:
FORM TYPE: SC 13G
SEC ACT: 1934 Act
SEC FILE NUMBER: 005-50927
FILM NUMBER: 15625154
BUSINESS ADDRESS:
STREET 1: 884 JOHNNIE DODDS BLVD
STREET 2: SUITE 201
CITY: MOUNT PLEASANT
STATE: SC
ZIP: 29464
BUSINESS PHONE: (832) 934-1825
MAIL ADDRESS:
STREET 1: 884 JOHNNIE DODDS BLVD
STREET 2: SUITE 201
CITY: MOUNT PLEASANT
STATE: SC
ZIP: 29464
FORMER COMPANY:
FORMER CONFORMED NAME: GOLF TRUST OF AMERICA INC
DATE OF NAME CHANGE: 19961002
FILED BY:
COMPANY DATA:
COMPANY CONFORMED NAME: JANUS CAPITAL MANAGEMENT LLC
CENTRAL INDEX KEY: 0000812295
STANDARD INDUSTRIAL CLASSIFICATION: UNKNOWN SIC - 0000 [0000]
IRS NUMBER: 753019302
STATE OF INCORPORATION: DE
FISCAL YEAR END: 1231
FILING VALUES:
FORM TYPE: SC 13G
BUSINESS ADDRESS:
STREET 1: 151 DETROIT ST.
CITY: DENVER
STATE: CO
ZIP: 80206-4805
BUSINESS PHONE: 3033333863
MAIL ADDRESS:
STREET 1: 151 DETROIT ST.
CITY: DENVER
STATE: CO
ZIP: 80206-4805
FORMER COMPANY:
FORMER CONFORMED NAME: JANUS CAPITAL GROUP INC
DATE OF NAME CHANGE: 20030103
FORMER COMPANY:
FORMER CONFORMED NAME: JANUS CAPITAL MANAGEMENT LLC
DATE OF NAME CHANGE: 20020424
FORMER COMPANY:
FORMER CONFORMED NAME: JANUS CAPITAL CORP
DATE OF NAME CHANGE: 19931213
SC 13G
1
ptx2102015.txt
PTX 12.31.14
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549
SCHEDULE 13G
Under the Securities Exchange Act of 1934
Amendment No.: *
Name of Issuer: PERNIX THERAPEUTICS HOLDINGS, INC
Title of Class of Securities: Common Stock
CUSIP Number: 71426V108
Date of Event Which Requires Filing of this Statement: 12/31/2014
Check the appropriate box to designate the rule pursuant to which this
Schedule is filed.
[X] Rule 13d-1(b) [ ] Rule 13d-1(c) [ ] Rule 13d-1(d)
*The remainder of this cover page shall be filled out for a reporting
person's initial filing on this form with respect to the subject class
of securities, and for any subsequent amendment containing information
which would alter the disclosures provided in a prior cover page.
The information required in the remainder of this cover page shall not
be deemed to be "filed" for the purpose of Section 18 of the Securities
Exchange Act of 1934 ("Act") or otherwise subject to the liabilities of
that section of the Act but shall be subject to all other provisions of
the Act (however, see the Notes).
CUSIP No.: 71426V108
1. NAME OF REPORTING PERSON S.S. OR I.R.S. IDENTIFICATION NO. OF ABOVE
PERSON Janus Capital Management LLC EIN #75-3019302
2. CHECK THE APPROPRIATE BOX IF A MEMBER OF A GROUP a. ___ b. ___
3. SEC USE ONLY
4. CITIZENSHIP OR PLACE OF ORGANIZATION Delaware
NUMBER OF SHARES BENEFICIALLY OWNED BY EACH REPORTING PERSON WITH:
5. SOLE VOTING POWER 3,618,226**
6. SHARED VOTING POWER 0**
7. SOLE DISPOSITIVE POWER 3,618,226**
8. SHARED DISPOSITIVE POWER 0**
9. AGGREGATE AMOUNT BENEFICIALLY OWNED BY EACH REPORTING PERSON
3,618,226**
10. CHECK BOX IF THE AGGREGATE AMOUNT IN ROW (9) EXCLUDES CERTAIN SHARES
Not applicable
11. PERCENT OF CLASS REPRESENTED BY AMOUNT IN ROW (9) 9.4%**
12. TYPE OF REPORTING PERSON IA, HC
**See Item 4 of this filing
Item 1.
(a). Name of Issuer: PERNIX THERAPEUTICS HOLDINGS, INC ("Pernix
Therapeutics")
(b). Address of Issuer's Principal Executive Offices:
10 North Park Place, Suite 201 Morristown, NJ 07960
Item 2.
(a).-(c). Name, Principal Business Address, and Citizenship of Persons
Filing:
(1) Janus Capital Management LLC ("Janus Capital") 151 Detroit Street
Denver, Colorado 80206 Citizenship: Delaware
(d). Title of Class of Securities: Common Stock
(e). CUSIP Number: 71426V108
Item 3.
This statement is filed pursuant to Rule 13d-1 (b) or 13d-2(b) and the
person filing, Janus Capital, is an investment adviser in accordance
with Section 240.13d-1(b)(ii)(E) as well as a parent holding
company/control person in accordance with Section 240.13d-1(b)(ii)(G).
See Item 4 for additional information.
Item 4. Ownership
The information in items 1 and 5 through 11 on the cover page(s) on
Schedule 13G is hereby incorporated by reference.
Janus Capital has a direct 96.81% ownership stake in INTECH Investment
Management ("INTECH") and a direct 100% ownership stake in Perkins
Investment Management LLC ("Perkins"). Due to the above ownership
structure, holdings for Janus Capital, Perkins and INTECH are aggregated
for purposes of this filing. Janus Capital, Perkins and INTECH are
registered investment advisers, each furnishing investment advice to
various investment companies registered under Section 8 of the
Investment Company Act of 1940 and to individual and institutional
clients (collectively referred to herein as "Managed Portfolios").
As a result of its role as investment adviser or sub-adviser to the
Managed Portfolios, Janus Capital may be deemed to be the beneficial
owner of 3,618,226 shares or 9.4% of the shares outstanding of Pernix
Therapeutics Common Stock held by such Managed Portfolios. However,
Janus Capital does not have the right to receive any dividends from, or
the proceeds from the sale of, the securities held in the Managed
Portfolios and disclaims any ownership associated with such rights.
Item 5. Ownership of Five Percent or Less of a Class
Not applicable.
Item 6. Ownership of More than Five Percent on Behalf of Another Person
The Managed Portfolios, set forth in Item 4 above, have the right to
receive all dividends from, and the proceeds from the sale of, the
securities held in their respective accounts.
The interest of any one such person does not exceed 5% of the class of
securities.
These shares were acquired in the ordinary course of business, and not
with the purpose of changing or influencing control of the Issuer.
Item 7. Identification and Classification of the Subsidiary Which
Acquired the Security Being Reported on by the Parent Holding Company
Not applicable.
Item 8. Identification and Classification of Members of the Group
Not applicable.
Item 9. Notice of Dissolution of Group
Not applicable.
Item 10. Certification
By signing below I certify that, to the best of my knowledge and belief,
the securities referred to above were acquired in the ordinary course of
business and were not acquired for the purpose of and do not have the
effect of changing or influencing the control of the issuer of such
securities and were not acquired in connection with or as a participant
in any transaction having such purposes or effect.
SIGNATURES
After reasonable inquiry and to the best of my knowledge and belief, I
certify that the information set forth in this statement is true,
complete and correct.
JANUS CAPITAL MANAGEMENT LLC
By /s/ David R. Kowalski 2/17/2015 David R. Kowalski,
Date Senior Vice President and CCO